SEARCH

SEARCH BY CITATION

Keywords:

  • Campylobacter jejuni;
  • Danish isolates;
  • Guillain–Barré syndrome;
  • multilocus sequence typing (MLST);
  • reactive arthritis

Abstract

  1. Top of page
  2. Abstract
  3. Introduction
  4. Material and methods
  5. Results
  6. Discussion
  7. Acknowledgements
  8. References

Aims:  To determine the diversity and population structure of Campylobacter jejuni (C. jejuni) isolates from Danish patients and to examine the association between multilocus sequence typing types and different clinical symptoms including gastroenteritis (GI), Guillain–Barré syndrome (GBS) and reactive arthritis (RA).

Methods and Results:  Multilocus sequence typing (MLST) was used to characterize 122 isolates, including 18 from patients with RA and 8 from patients with GBS. The GI and RA isolates were collected in Denmark during 2002–2003 and the GBS isolates were obtained from other countries. In overall, 51 sequence types (STs) were identified within 18 clonal complexes (CCs). Of these three CCs, ST-21, ST-45 and ST-22 clonal complexes accounted for 64 percent of all isolates. The GBS isolates in this study significantly grouped into the ST-22 clonal complex, consistent with the PubMLST database isolates. There was no significant clustering of the RA isolates.

Conclusions:  Isolates from Denmark were found to be highly genetically diverse. GBS isolates grouped significantly with clonal complex ST-22, but the absence of clustering of RA isolates indicated that the phylogenetic background for this sequela could not be reconstructed using variation in MLST loci. Possibly, putative RA-associated genes may vary, by recombination or expression differences, independent of MLST loci.

Significance and Impact of the Study:  MLST typing of C. jejuni isolates from Danish patients with gastroenteritis confirmed that the diversity of clones in Denmark is comparable to that in other European countries. Furthermore, a verification of the grouping of GBS isolates compared to RA isolates provides information about evolution of the bacterial population resulting in this important sequela.


Introduction

  1. Top of page
  2. Abstract
  3. Introduction
  4. Material and methods
  5. Results
  6. Discussion
  7. Acknowledgements
  8. References

Campylobacter jejuni is the leading bacterial cause of gastroenteritis in the industrialized world causing almost 500 million annual cases worldwide (Friedman et al. 2000). In Denmark, the prevalence of campylobacteriosis was 71 cases per 100 000 in 2007 (http://www.ssi.dk). The number of laboratory-confirmed cases has increased in Denmark over a 10-year period from 2665 cases in 1997 to 3868 cases in 2007 and currently accounts for more than twice that of notifications of Salmonella, consistent with other developed countries. Most Campylobacter infections are sporadic and several risk factors have been identified including consumption of raw milk or contaminated water, red meat and poultry, contact with pets (especially birds and cats), and international travel (Kapperud et al. 1992).

The symptoms of campylobacteriosis vary from diarrhoea to severe invasive disease and sequelae including Guillain–Barré syndrome (GBS), a demyelinating disorder resulting in acute muscular paralysis. Affected people develop weakness of the limbs and the respiratory muscles and areflexia (Nachamkin et al. 1998). Approximately one case of GBS occurs for every 1000 cases of campylobacteriosis and of these, 20% are left with some disablement, sometimes needing mechanical ventilation. Approximately 2–3% of cases result in death with many more occurring in the developing countries of world (Willison and O′ Hanlon 2000). GBS is believed to be a result of molecular mimicry of lipooligosaccharide, a part of C. jejunis cell envelope, and sugar moieties on nerve gangliosides. Antibodies raised during Campylobacter infection containing such ganglioside mimics and can cross-react with gangliosides in the patients and lead to demyelinization of nerves and degeneration of axons (Nachamkin et al. 1999; Ang et al. 2004).

Campylobacteriosis is also associated with another immune-mediated sequela, reactive arthritis (RA), a reactive arthropathy. It occurs in between 0·6% and 24% of the patients (Pope et al. 2007). Multiple joints can be affected, in particular the knee joint, with symptoms of pain and incapacitation usually resolving completely within several months (Jansen et al. 2002).

Discriminatory typing methods to study the population genetics of C. jejuni isolates are crucial to improve our understanding of the epidemiology and genetic background of this pathogen. Multilocus sequence typing (MLST) has proved to be a valuable typing tool for discriminating Campylobacter isolates and defining population structure (Dingle et al. 2001a). MLST is based upon an allelic profile obtained by sequence analysis of seven housekeeping genes. The allelic profile is summarized by a sequence type assigned using an online database (PubMLST). Relatedness can be inferred and isolates can be grouped as clonal complexes. The advantages of MLST, compared to other molecular methods such as pulse-field gel electrophoresis, are standardized nomenclature, free access to the database and direct comparability of results between different studies/laboratories.

Previous studies have shown that certain genotypes are more common cause of disease in humans while others may be less important (Manning et al. 2003; Siemer et al. 2004; Sheppard et al. 2009a,b). In this study, the genetic diversity among isolates from human disease in Denmark was investigated and the relationship between Sequence types (STs) and Clonal complexes (CCs) and different clinical symptoms of the patients were determined.

Material and methods

  1. Top of page
  2. Abstract
  3. Introduction
  4. Material and methods
  5. Results
  6. Discussion
  7. Acknowledgements
  8. References

Strain collection

During the period 2002–2003 consecutive faecal isolates were obtained in the diagnostic laboratory at Statens Serum Institut (SSI). On a follow up study for sequelae cases of human gastroenteritis (n = 96), reactive arthritis (n = 18) and GBS (n = 0) were defined (Schiellerup et al. 2008). Because no GBS cases were detected during the investigation, eight previously described GBS isolates originated from China, Japan and Mexico were included in the study (Engberg et al. 2001; Nachamkin et al. 2002; Leonard et al. 2004). In the phylogeny analysis, additional GBS MLST types were further extracted from the MLST database (PubMLST).

Bacterial growth and preparation of chromosomal DNA

The isolates were cultured on Campylobacter blood free medium (mCCDA) agar plates (SSI, LAB112), and subsequently grown on blood agar plates with 5% yeast for 24–48 h at 37°C under microaerophilic conditions. For isolation of chromosomal DNA, a suspension of C. jejuni cells was prepared in 250 μl PBS in a 0·5 ml eppendorf tube. The suspension was vortexed briefly, heated at 100°C for 10 min and centrifuged at 10 000 g for 10 min. The supernatant was removed and stored at −20°C until it was required for PCR amplification.

PCR amplification and sequencing

Internal fragments of seven gene targets (aspA; glnA; gltA; glyA; pgm; tkt; uncA) were amplified by PCR with primers stated at the MLST database (PubMLST). The amplification reaction mixture comprised c. 10 ng Campylobacter chromosomal DNA, 1 μmol l−1 each PCR primer, 1× PCR buffer, 1·5 mmol l−1 MgCl2, 0·8 mmol l−1 deoxynucleoside triphosphates and 1·25 U of Amplitaq polymerase. Reaction conditions were 95°C for 3 min, 35 cycles of 94°C for 20 s, annealing temperature for each primer set at 50°C for 20 s, and extension at 72°C for 1 min, with a final extension step for 5 min. PCR product was confirmed by agarose gel electrophoresis. PCR products were purified by precipitation with 20% polyethylene glycol–2·5 mol l−1 NaCl and their nucleotide sequences were determined on each strand with BigDye reaction mix (Applied Biosystems) in accordance with the manufacturers’ instructions.

Allele and ST assignment

Sequences were commercially determined on both DNA strands and assembled from resultant chromatograms using the Staden suite of computer programmes (Staden, 1996). Consensus sequences for each allele were assigned an allele number and the 7-locus (3309 bp) ST by interrogation of the Campylobacter MLST database (http://pubmlst.org/campylobacter/). Novel alleles and STs were submitted to the MLST database to obtain new numbers.

Phylogeny analysis

Profiles of 7-locus allelic were concatenated and used to construct genealogies using two methods for inferring evolutionary relationships among C. jejuni STs. First relatedness of isolates was represented by a dendrogram constructed by cluster analysis using the unweighted pair group method with arithmetic mean (UPGMA) in the programme start2, available at http://www.pubmlst.org (Jolley et al. 2001). The second phylogenetic analysis estimated the clonal genealogy of STs using the model-based approach to determine bacterial microevolution: ClonalFrame (Didelot and Falush 2007). This is a model that calculates clonal relationships with improved accuracy as it distinguishes point mutations from imported chromosomal recombination events – the source of the majority of allelic polymorphisms. Analysis was carried out on concatenated sequences representing 51 STs, from 122 isolates from RA, GBS and gastroenteritis. The programme was run with 50 000 burn-in followed by 50 000 subsequent iterations. The consensus trees represent combined data from three independent runs with 50% majority rule consensus required for inference of relatedness.

Because of statistical limitations, we included and compared the typed GBS isolates with the GBS isolates in the PubMLST database that are distributed with the complexes ST-22 (30·5%), ST-21 (16·5%), ST-403 (8%), ST-508, 61 and 42 (5·5%), ST-48, 658, 52, 362, 607 and 206 (2·7%) and isolates currently unassigned to a lineage with 11% (http://www.mlst.net).

Statistical analysis

Association between the clonal complex and the clinical diagnosis was assessed by Fisher's exact test (also known as the Fisher–Freeman–Halton test) using software sas (SAS Institute, Cary, NC). Counts from the rare CCs were grouped into category Other.

Results

  1. Top of page
  2. Abstract
  3. Introduction
  4. Material and methods
  5. Results
  6. Discussion
  7. Acknowledgements
  8. References

Diversity of sequence types (ST) and clonal complexes (CC)

Among the 122 isolates, 51 STs clustering in 18 clonal complexes were identified. Three clonal complexes, ST-21, ST-45 and ST-22, predominated and accounted for nearly 64% (78/122). In the ST-21 complex, ST-388 and ST-53 were the most common sequence types each representing 6·6%. The ST-45 complex, the second most common group, was dominated by ST-45 with 13·9%. The ST-22 complex represented only two groups, ST-22 and ST-567, with the ST-22 as main sequence type with 9·9%. Despite the fact that the ST-21 complex was the most frequent group, the subgroup ST-45 in ST-45 complex was found to be the most common, accounting for 17 out of 122 isolates. A number of isolates were found in CCs only represented by one or two STs (Table 1).

Table 1.   Sequence types and clonal complexes among 122 human isolates grouped as clinical disease and results in parenthesis from Fisher′s exact test (P = 0·0022) for the most frequent CCs (21, 22, 42 and 48). For CCs with more than one isolate, the accumulated value is shown in the row for the last isolate
Isolate numberaspglngltglypgmtktuncST‡CC§diagn.ST freq. (FE)
  1. CC, clonal complexes, ST, sequence types; GBS, Guillain–Barré syndrome; GI, gastroenteritis; RA, reactive arthritis.

  2. *+1557, 1563, 1572.

  3. †+1514, 1521, 1529, 1541, 1547, 1555, 1556, 1558, 1559, 1560.

  4. ‡Sequence type.

  5. §Clonal complex.

  6. ¶UN, currently unassigned to a lineage.

1575, 1576, 1580, 158113643332222GBS4
1577136433156722GBS1 (0·918)
1579, 15821242425698167242GBS2 (0·33)
1578810162111262049354GBS1 (1·90)
13197152832363708UN¶RA1
1372331603079196253614UNRA1
1209331603079104625UNUNRA1
1152, 133621132152121RA2
1142, 1149, 1172212132155321RA3 (5·61)
1015, 131313643332222RA2 (2·06)
1092, 1231471041714545RA2
103747104427113745RA1
1014, 1046471010231258945RA2 (4·13)
1093, 1094241219625295548RA2 (1·18)
1312142263121961RA1
151521121212153709UNGI1
1417, 1418, 156621132152121GI3
1535, 1551211262152421GI2
1540, 154281632114421GI2
1032, 1525, 1567, 1571211232155021GI4
1526, 1543, 1544, 1545, 1548212132155321GI5
1058, 1530, 1550215221525121GI3
1025, 1076, 1416, 1422, 1553*4311321538821GI8
1517215331581521GI1
150627123215146121GI1
152021141625182021GI1
1516211773215182321GI1
15652143215205721GI1 (29·9)
1047, 1049, 1084, 1528, 1564, 157413643332222GI6
151912424333261522GI1 (11·02)
1023, 1533, 153912345934242GI3 (3·93)
1006, 1091, 1507, 1508, 1510†471041714545GI15
1028, 1531, 153247104427113745GI4
1509, 1511471044251158345GI2
15044210417178245GI1
154947104174240645GI1 (22·03)
1057, 153724127154848GI2
15247452111542948GI1
150024141962547548GI1
1033, 10434341271550548GI2 (6·29)
152331517111164949GI1
156992521022365252GI1
1534221532315290206GI1
1027, 1522, 1554, 156292462456257257GI4
15139175624562543257GI1
1074712243682353GI1
1538717521036353353GI1
15129112521136936353GI1
152772522362132353GI1
10717175213363510353GI1
1552, 15688102211126354354GI2
1502, 1536102743196187270403GI2
15707172152331251443GI1
15187171615233122687443GI1
129816602412281508508GI1
150110150991207652678677GI1
1503, 1561108150871207652794677GI2
157321292858255813321332GI1

Association between clonal complexes and clinical symptoms

The distribution of the 122 C. jejuni isolates and comparison of the gastroenteritis, GBS and RA isolates were investigated (Fig. 1). The isolates from gastroenteritis were represented in all CCs except ST-61. GBS isolates were found in ST-22, 42 and 354 complexes. Isolates from RA were found in the ST-21, 45, 42, 48 and 61 complexes. The isolates from gastroenteritis were most frequently represented with the ST-21 (34%) and ST-45 complexes (23%), GBS isolates with the ST-22 (63%) and ST-42 complexes and RA more evenly distributed with the complexes ST-21 (28%), ST-45 (28%), ST-22 (11%) and ST-48 (11%).

image

Figure 1.  Distribution of the CCs among the 122 isolates with different clinical outcomes in this study. Gastroenteritis are shown in grey, Guillain–Barré syndrome (GBS) in white and reactive arthritis in black. The sequence types (ST)-21 complex are shown to be the most frequent clonal complex followed by the ST-45 and ST-22 complexes. The GBS isolates are represented in the ST-22, ST-42 and ST-354 complexes and found to be significantly overrepresented in the ST-22 complex.

Download figure to PowerPoint

The clonal complex frequencies varied within the three clinical outcome groups. For most frequent CCs appearing in at least two different clinical diagnosis types, the significance of association with diagnosis was confirmed by Fisher′s exact test. Both the observed frequency and the frequency expected under the hypothesis of no association (homogeneity) are given (Table 1). The cell frequencies show far more observed ST-22 and ST-42 complexes than expected among GBS patients. Fisher′s exact test demonstrates a significant association between the CC and the diagnosis (P = 0·0022).

Phylogeny and clustering of the isolates

The UPGMA dendrogram cluster analysis (Fig. 2) showed a grouping of isolates in relation to clonal complexes (shown with brackets). The sequelae (GBS and RA), marked in bold, were not found to clearly cluster within these groups. There is, however, some evidence of clustering of GBS strains within the ST-22 complex even though there is a limited number of isolates. On the clonal frame genealogy (Fig. 3), the three different symptoms are found to be distributed evenly in the tree, not indicating any clustering of CCs or STs according to symptoms.

image

Figure 2.  Dendrogram demonstrating the phylogenetic relationship between the 122 isolates. Majority of strains were from patients with gastroenteritis, strains from patients with sequelae [Reactive arthritis (RA) and Guillain–Barré syndrome (GBS)] are marked in bold. The isolates clustered in relation to clonal complexes (marked with brackets). A minor clustering of GBS to ST-22 was observed.

Download figure to PowerPoint

image

Figure 3.  Clonal frame tree demonstrating the genetic relationships of sequence types between Campylobacter jejuni isolated from patients with gastroenteritis (GI), Reactive arthritis (RA) and Guillain–Barré Syndrome (GBS). GI are shown as light grey, GBS white and RA dark grey. Combinations of sequelae are shown as GI + RA + GBS with squares and GI + RA with lines. The clonal frame tree includes GBS isolates from the multilocus sequence typing database (PubMLST).

Download figure to PowerPoint

Discussion

  1. Top of page
  2. Abstract
  3. Introduction
  4. Material and methods
  5. Results
  6. Discussion
  7. Acknowledgements
  8. References

We have examined the association between C. jejuni genotypes and different clinical sequelae. Campylobacter jejuni isolates from a range of sources, geographical locations in Denmark and patients diagnosed with either gastroenteritis or RA were discriminated and formed the basis of our study. GBS isolates were added to the dataset from previously described cases outside the studied population. By using MLST, the Danish isolates proved to be highly diverse with a total of 51 sequence types belonging to 18 clonal complexes. This finding is consistent with other studies examining C. jejuni isolates from a single geographic location (Duim et al. 2003; Mickan et al. 2007). However, our MLST data also identified a number of frequently described sequence types that have formerly been associated with human infection (Manning et al. 2003; Dingle et al. 2005; Sheppard et al. 2009b).

The ST-21 complex was particularly common with 38%, similar to previous studies, where it accounted for up to 20–33% of the isolates (Dingle et al. 2001a; Schouls et al. 2003; Sopwith et al. 2006; Karenlampi et al. 2007). The prevalence of the ST-21 complex in Danish isolates is also found to be consistent with the MLST surveys of Campylobacter in other European countries, (Duim et al. 2003; Mickan et al. 2007; Kwan et al. 2008; McTavish et al. 2008). The other major clonal complex in our study, the ST-45 complex, accounted for approximately one quarter of the isolates and the ST-48 complex was found with the frequency of 6·6%. These complexes have also been identified in other countries and from multiple sources (Dingle et al. 2001a; McTavish et al. 2008). Isolates from patients diagnosed with RA were not found to be associated with one or few of the clonal complexes. Therefore, we suggest that specific RA features rather involve differential expression of virulence factors that might be revealed by expression analysis of RA isolates or because of rapid recombination of disease associated genes. Furthermore, host specific genetics might be involved.

The ST-22 complex accounted for 10% of the isolates and interestingly it was significantly overrepresented in the collection of GBS isolates both in our study as well as in the PubMLST database. The ST-22 complex was also described in isolates from several countries and animal sources (Duim et al. 2003; Kwan et al. 2008), but not as frequently as the ST-21 and ST45 complexes. A study by Dingle et al. 2001b suggested a possible relatedness between the ST-22 complex and GBS isolates and this notion is supported by our data. Furthermore, the authors found that the ST-45 complex was underrepresented among GBS isolates (Dingle et al. 2001b). Once more our data and the GBS collection in the MLST database confirm this by the fact that to date no GBS isolates carry the ST-45, despite the fact that this is the most common sequence type identified in our study. The association between GBS and the two clonal complexes ST-22 and ST-42 could be explained by a more frequently expression of the GBS-related Gm1 gangliosides, but we have no evidence of this. By comparison of the Danish isolates with the PubMLST database (including the global isolates), we found that the Danish isolates are similar to those obtained from other parts of the world and, therefore, geographical location of the isolates is not correlated with sequence type. In addition, the global GBS isolates have been compared with the GBS isolates in our study and shows the same results. In an earlier study, the GBS isolates were analysed by other methods and the population was found to be heterogenic (Engberg et al. 2001). Further analysis of the GBS isolates by DNA microarrays confirmed significant genomic heterogeneity among the isolates (Leonard et al. 2004). Despite these results, we believe that the results presented here together with those of others (Dingle et al. 2001b) suggest a possible correlation between certain complexes such as ST-22 complex, and the development of GBS.

Acknowledgements

  1. Top of page
  2. Abstract
  3. Introduction
  4. Material and methods
  5. Results
  6. Discussion
  7. Acknowledgements
  8. References

We would like to thank Christina C. Vegge from University of Copenhagen and Frances Colles, Roisin Ure and Keith Jolley from University of Oxford for helpful advice. Furthermore, Azra Kurbasic, SSI, for suggestions regarding the statistical analysis.

This publication made use of the Campylobacter MultiLocus Sequence Typing website (http://pubmlst.org/campylobacter/) developed by Keith Jolley, sited at the University of Oxford, United Kingdom. Lene Nørby Nielsen was partially supported by the Research School for Biotechnology (FOBI). K.A. Krogfelt and L.N. Nielsen are members of MedVetNet, Network of excellence, supported by FP 7.

References

  1. Top of page
  2. Abstract
  3. Introduction
  4. Material and methods
  5. Results
  6. Discussion
  7. Acknowledgements
  8. References
  • Ang, C.W., Jacobs, B.C. and Laman, J.D. (2004) The Guillain-Barré syndrome: a true case of molecular mimicry. Trends Immunol, 25, 6166.
  • Didelot, X. and Falush, D. (2007) Inference of bacterial microevolution using multilocus sequence data. Genetics, 175, 12511266.
  • Dingle, K.E., Colles, F.M., Wareing, D.R., Ure, R., Fox, A.J., Bolton, F.E., Bootsma, H.J., Willems, R.J. et al. (2001a) Multilocus sequence typing system for Campylobacter jejuni. J Clin Microbiol, 39, 1423.
  • Dingle, K.E., Van Den Braak, N., Colles, F.M., Price, L.J., Woodward, D.l., Rodgers, F.G., Endtz, H.P., Van Belkum, A. et al. (2001b) Sequence typing confirms that Campylobacter jejuni strains associated with Guillain-Barré and Miller-Fisher syndromes are of diverse genetic linage, serotype, and flagella type. J Clin Microbiol, 39, 33463349.
  • Dingle, K.E., Colles, F.M., Falush, D. and Maiden, M. (2005) Sequence typing and comparison of population biology of Campylobacter coli and Campylobacter jejuni. J Clin Microbiol, 43, 340347.
  • Duim, B., Godschalk, P.C., Van der Braak, N., Dingle, K.E., Dijkstra, J.R., Leyde, E., Van der Plas, J., Colles, F.M. et al. (2003) Molecular eidence for dissemination of unique Campylobacter jejuni clones in Caracao, Netherlands Antilles. J Clin Microbiol, 41, 55935597.
  • Engberg, J., Nachamkin, I., Fussing, V., Mckhann, G.M., Griffin, J.W., Piffaretti, C.J., Nielsen, E.M. and Gerner-Smidt, P. (2001) Absence of clonality of Campylobacter jejuni in serotypes other than HS:19 associated with Guillain-Barré syndrome and gastroenteritis. J Infect Dis, 184, 215220.
  • Friedman, C.R., Neimann, J., Wegener, H.C. and Tauxe, R.V. (2000) Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In Campylobacter ed. Nachamkin, I. and Blaser, M.J. pp. 121138. Washington, DC: American Society for Microbiology Press.
  • Jansen, L.M., Van Schaardenburg, D., Van der Horst-bruinsma, I.E. and Dijkmans, B.A. (2002) One year outcome of undifferentiated polyarthritis. Ann Rheum Dis, 61, 700703.
  • Jolley, K.A., Feil, E.J., Chan, M.S. and Maiden, M.C. (2001) Sequence type analysis and recombinatorial tests (START). Bioinformatics, 17, 12301231.
  • Kapperud, G., Skjerve, E., Bean, N.H., Ostroff, S.M. and Lassen, J. (1992) Risk factors for sporadic Campylobacter infections: results of a case-control study in southeastern Norway. J Clin Microbiol, 30, 31173121.
  • Karenlampi, R., Rautelin, H., Schonberg-Norio, D., Paulin, L. and Hanninen, M.L. (2007) Longitudinal study of Finnish Campylobacter jejuni and C. coli isolates from humans, using mutilocus sequence typing, including comparison with epideliological data and isolates from poultry and cattle. Appl Environ Microbiol, 73, 148155.
  • Kwan, P.S., Birtles, A., Bolton, F.J., French, N.P., Robinson, S.E., Newbold, L.S., Upton, M. and Fox, A.J. (2008) Longitudinal study of the molecular epidemiology of Campylobacter jejuni in cattle on dairy farms. Appl Environ Microbiol, 74, 36263633.
  • Leonard, E.E., Tompkins, L.S., Falkow, S. and Nachamkin, I. (2004) Comparison of Campylobacter jejuni isolates implicated in Guillain-Barre syndrome and strains that cause enteritis by a DNA microarray. Infect Immun, 72, 11991203.
  • Manning, G., Dowson, C.G., Bagnall, M.C., Ahmed, I.H., West, M. and Newell, D.G. (2003) Multilocus sequence typing for comparison of veterinary and human isolates of Campylobacter jejuni. Appl Environ Microbiol, 69, 63706379.
  • McTavish, S.M., Pope, C.E., Nicol, C., Sexton, K., French, N. and Carter, P.E. (2008) Wide geographical distribution of internationally rare Campylobacter clones within New Zealand. Epidemiol Infect, 136, 12441252.
  • Mickan, L., Doyle, R., Valcanis, M., Dingle, K.E., Unicomb, L. and Lanser, J. (2007) Multilocus sequence typing of Campylobacter jejuni isolates from New South Wales, Australia. J Appl Microbiol, 102, 144152.
  • Nachamkin, I., Allos, B.M. and Ho, T. (1998) Campylobacter species and Guillain-Barré syndrome. Clin Microbiol Rev, 11, 555567.
  • Nachamkin, I., Ung, H., Moran, A.P., Yoo, D., Prendergast, M.M., Nicholson, M.A., Sheikh, K., Ho, T. et al. (1999) Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States. J Infect Dis, 179, 11831189.
  • Nachamkin, I., Liu, J., Li, M., Ung, H., Moran, A.P., Prendergast, M.M. and Sheikh, K. (2002) Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope. Infect Immun, 70, 52995303.
  • Pope, C., Wilson, J., Toboada, E.N., MacKinnon, J., Filipe Alves, C.A., Nash, J.H., Rahn, K. and Tannock, G.W. (2007) Epidemiology, relative invasive ability, molecular characterization, and competitive performance of Campylobacter jejuni strains in the chicken gut. Appl Environ Microbiol, 73, 79597966.
  • Schiellerup, P., Krogfelt, K.A. and Locht, H. (2008) A comparison of self-reported joint symptoms following infection with different enteric pathogens: effect of HLA-B27. J Rheumatol, 35, 480487.
  • Schouls, L.M., Reulen, S., Duim, B., Wagenaar, J.A., Willems, R.J., Dingle, K.E., Colles, F.M. and Van Embden, J.D. (2003) Comparative genotyping of Campylobacter jejuni by amplified fragment length polymorphism, multilocus sequence typing, and short repeat sequencing: strain diversity, host range, and recombination. J Clin Microbiol, 41, 1526.
  • Sheppard, S.K., Dallas, J., Strachan, N.J., MacRae, M., McCarthy, N.D., Wilson, D.J., Gormley, F.J., Falush, D. et al. (2009a) Campylobacter Genotyping to Determine the Source of Human Infection. Clin Infect Dis 48, 10721078.
  • Sheppard, S.K., Dallas, J.F., MacRae, M., McCarthy, N.D., Sproston, E.L., Gormley, F.J., Strachan, N.J.C., Ogden, I.D. et al. (2009b) Campylobacter genotypes from food animals, environmental sources and clinical disease in Scotland 2005/6. Int J Food Microbiol doi: 10.1016/j.ijfoodmicro.2009.02.010.
  • Siemer, B.L., Harrington, C.S., Nielsen, E.M., Borck, B., Nielsen, N.L., Engberg, J. and On, S.L. (2004) Genetic relatedness among Campylobacter jejuni serotyped isolates of diverse origin as determined by numerical analysis of amplified fragment length polymorphism (AFLP) profiles. J Appl Microbiol, 96, 795802.
  • Sopwith, W., Birtles, A., Matthews, M., Fox, A., Gee, S., Painter, M., Regan, M., Syed, Q. et al. (2006) Campylobacter jejuni multilocus sequence types in humans, northwest England, 2003-2004. Emerg Infect Dis, 12, 15001507.
  • Staden, R. (1996) The Staden sequence analysis package. Mol Bio/Technol, 5, 233241.
  • Willison, H.J. and O′ Hanlon, G.M. (2000) Anti-glycosphingolipid antibodies and Guillain-Barré syndrome. In Campylobacter ed. Nachamkin, I. and Blaser, M.J. pp. 241258. Washington, DC: American Society for Microbiology Press.